Access to CARe: A Narrative of Real‐World Medical Decision‐Making to Access Chimeric Antigen Receptor (CAR) T‐Cell Therapy in Children, Adolescents, and Young Adults

Documenti analoghi

• Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma
  di: Subongkoch Subhadhirasakul, et al.
  Pubblicazione: (2026)
• Diagnostic pitfalls in assessment of ferritin following CAR‐T‐cell therapy: Understanding the hook effect
  di: Roa Harb, et al.
  Pubblicazione: (2024)
• How I Approach Ethical Considerations for Pediatric Phase I CAR T‐Cell Trials
  di: Sarah W. Peters, et al.
  Pubblicazione: (2025)
• Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model
  di: Katelyn Oranges, et al.
  Pubblicazione: (2026)
• Weathering the storm when the end of the road is near: A qualitative analysis of supportive care needs during CAR T‐cell therapy in pediatrics
  di: Angela Steineck, et al.
  Pubblicazione: (2024)